Everest Group Ltd (EG) Stock News

Constellation Energy secured 920 megawatts of long-term power purchase agreements in Q2, including a major 176 MW contract with Walmart spanning two 15-year terms. The company also made significant progress on its Microsoft deal with NRC approval for the Crane Clean Energy Center. Constellation projects 20% annualized earnings growth through 2029, with additional upside from future contracts.

Klépierre, Europe's leading shopping mall operator, has raised its full-year 2026 guidance with EBITDA expected to reach a minimum of €1,150 million. The company demonstrated strong execution in a dynamic retail market, driving organic growth. As of July 31, 2026, the company had 286.86 million shares outstanding.

The Schall Law Firm is seeking investors to join a class action lawsuit against Regeneron Pharmaceuticals for securities fraud. The company allegedly made false and misleading statements about its Phase III Fianlimab-Libtayo study, claiming it was likely to succeed when it actually failed to demonstrate clinical differentiation from competing therapies. Investors who purchased securities between August 1, 2025 and May 15, 2026 are encouraged to participate before the September 14, 2026 deadline.

Regeneron Pharmaceuticals faces a securities class action lawsuit after failing to disclose critical information about its Phase 3 clinical trial for a melanoma treatment combination therapy. The company allegedly made false statements about trial progress while concealing that preliminary statistical assumptions were flawed and the treatment showed no meaningful differentiation over standard therapies. The trial ultimately failed to reach statistical significance, resulting in an $11 billion market cap loss. The class period covers August 1, 2025 to May 15, 2026.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary focus is on Erasca, Inc., which allegedly made false and misleading statements about its lead oncology drug candidate ERAS-0015, claiming it was 'best-in-class' while failing to disclose improper comparisons to competitors and lacking reasonable basis. The firm is seeking lead plaintiffs with an August 10, 2026 deadline for Erasca and August 4, 2026 for PicS N.V.

A securities fraud class action lawsuit has been filed against Regeneron Pharmaceuticals for allegedly misleading investors about the success of its Phase III Fianlimab-Libtayo clinical trial. The stock dropped 6.2% on April 29, 2026, and 9.8% on May 15, 2026, after the company announced the study failed to achieve statistical significance. Investors have until September 14, 2026, to request lead plaintiff status.

Regeneron Pharmaceuticals faces a securities class action lawsuit after failing to disclose critical information about its Phase 3 clinical trial for a melanoma treatment combination therapy. The company allegedly made misleading statements about the trial's progress while concealing that preliminary statistical assumptions were flawed and the primary endpoint was unlikely to be achieved. The trial ultimately failed to reach statistical significance, resulting in an $11 billion market cap loss. The class period covers August 1, 2025 to May 15, 2026, with a lead plaintiff deadline of September 14, 2026.

iBUYPOWER, a gaming PC system integrator with 25 years of experience, has expanded into the professional workstation market with a new line of prebuilt and custom systems. The company simultaneously enhanced its warranty coverage to three years for both parts and labor, up from two years previously. The workstation lineup ranges from $3,349 to $19,149 and features configurations with Intel Core Ultra, AMD Ryzen, and high-end GPU options including NVIDIA RTX PRO Blackwell.

Rosen Law Firm reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors who purchased stock between April 16, 2025 and May 4, 2026 of the August 3, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operations, when defendants knew of significant viability problems that would negatively impact the business.

Regeneron Pharmaceuticals faces a securities class action lawsuit after failing to disclose critical information about its Phase 3 clinical trial for a melanoma treatment combination. The company allegedly made misleading statements about the trial's progress while concealing that preliminary statistical assumptions were flawed and the primary endpoint was unlikely to be achieved. The trial ultimately failed to reach statistical significance on May 15, 2026, resulting in an $11 billion market cap loss. The lawsuit covers investors who purchased shares between August 1, 2025 and May 15, 2026.

A class action lawsuit has been filed against Megan Holdings Limited (NASDAQ: MGN) in the U.S. District Court for the Southern District of New York. The complaint alleges that the company issued materially false statements and failed to disclose a market manipulation and fraudulent promotion scheme involving social media misinformation. The lawsuit covers investors who purchased Megan securities between September 26, 2025 and March 25, 2026. The deadline to apply as lead plaintiff is September 8, 2026.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against PicS N.V., alleging the company made false and misleading statements in its January 2026 IPO offering documents. The lawsuit claims PicS failed to disclose deficient credit evaluation procedures, material reclassifications of credit exposures, undisclosed high Stage 3 formation rates, overstated credit models, and deteriorating customer credit quality. The lead plaintiff deadline is August 4, 2026.

Brancous LP1, a shareholder of Braemar Hotels & Resorts, criticizes the Board for wasting company resources attacking shareholders instead of negotiating a lower Ashford termination payment. The shareholder claims the Board is pursuing a 'stealth liquidation' through asset sales to trigger a $480 million Change of Control payment to Ashford, which Brancous estimates at $7.00 per share. Brancous demands the Board declare a special dividend of at least $1.00 per share, renegotiate the Ashford payment, and allow shareholders to elect an independent Board.

TEGNA Inc. announced that Scott Gill has been promoted to vice president of technology and operations, where he will oversee engineering, technology and sports operations across the company's 64 local television stations. Gill, who joined TEGNA in 2012, will lead efforts to modernize infrastructure and support local journalism delivery across multiple platforms.

Rosen Law Firm is encouraging investors who purchased securities of First Solar, Veritone, and Alibaba during specified periods to join class action lawsuits. First Solar faces allegations of overstating its capacity to manage U.S. tariff impacts and understating negative effects on 2026 fiscal year performance. The lead plaintiff deadline for First Solar is August 24, 2026.

Bernstein Liebhard LLP has announced multiple securities class action lawsuits against Megan Holdings Limited (MGN), Photronics, Inc. (PLAB), and GRAIL, Inc. (GRAL). The lawsuits allege that defendants made materially false and misleading statements regarding their businesses and operations, causing securities to trade at artificially inflated prices. Investors who suffered losses during the respective class periods are encouraged to contact the firm.

Rosen Law Firm is alerting Sportradar Group AG investors who purchased shares between November 7, 2024 and April 21, 2026 about a July 17, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Sportradar made false statements about compliance and ethics while secretly working with black-market gambling operators and maintaining inadequate Know-Your-Customer processes.

Rosen Law Firm has filed a class action lawsuit on behalf of Genius Group Limited (GNS) investors who purchased or sold securities between April 12, 2022 and May 30, 2025. The lawsuit alleges that Citadel Securities LLC and Virtu Americas LLC engaged in illegal 'spoofing' practices—submitting and cancelling orders without intent to execute them—to manipulate stock prices and mislead market participants about supply, demand, and volatility. The deadline to serve as lead plaintiff is August 28, 2026.

Rosen Law Firm is encouraging investors who purchased Badger Meter common stock between April 18, 2024 and April 16, 2026 to join a securities class action lawsuit. The lawsuit alleges that Badger Meter made materially false and misleading statements about its financial results and growth prospects by concealing a practice of pulling forward customer orders to recognize revenue early, which masked weakening demand and deteriorating order trends. The lead plaintiff deadline is August 3, 2026.

THEA, a predictive behavioral AI network focused on risk markets, announced $8 million in financing led by Maven11 Capital. However, the article begins with a retraction notice advising readers to disregard the original news release, creating significant uncertainty about the announcement's validity.

Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and cash burn. The lead plaintiff deadline is August 11, 2026. The firm is also investigating potential securities claims for ADMA Biologics and DNOW Inc.

Rosen Law Firm is notifying investors in FS KKR Capital Corp. (FSK), ChampionX Corporation (CHX), and Lucid Group, Inc. (LCID) of upcoming lead plaintiff deadlines in securities class action lawsuits. FSK investors have until July 6, 2026, while CHX and LCID have July 14 and unspecified deadlines respectively. The lawsuits allege false statements regarding portfolio valuations, operational effectiveness, and business prospects.

Rosen Law Firm announces securities class action lawsuits against AeroVironment, Futu Holdings Limited, and TruBridge, Inc. AeroVironment is accused of making false statements about competition risks related to U.S. Space Force contracts. Investors with losses exceeding $100,000 are encouraged to join the class actions before the July 27, 2026 lead plaintiff deadline.

Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential securities law violations and breaches of fiduciary duties related to proposed mergers and acquisitions. The firm is examining whether shareholders are receiving fair consideration and whether insider benefits may be prioritized over ordinary shareholder interests.

Rosen Law Firm is notifying investors about ongoing securities class action lawsuits against Roblox Corporation and FS KKR Capital Corp. The Roblox lawsuit alleges the company made materially false statements about its organic growth potential, concealing that age verification rollout would cause significant growth slowdown. Investors who purchased shares during specified periods are encouraged to join the class action before respective deadlines.

Dimensional Fund Advisors Ltd. has disclosed a 1.14% interest in Segro PLC comprising 15,392,411 ordinary shares as of June 25, 2026. The disclosure includes a sale of 1,532 shares at 8.80 GBP per unit and a transfer in of 4,680 shares. Dimensional also made concurrent disclosures regarding Prologis Inc.

Rosen Law Firm is encouraging investors with losses exceeding $100,000 in Regencell Bioscience Holdings Limited, FS KKR Capital Corp., and Microsoft to join securities class action lawsuits. The firm has set a June 23, 2026 deadline for lead plaintiff claims. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities and regulatory risks.

Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited (RGC) and AeroVironment, Inc. (AVAV) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and financial exposure during their respective class periods.

Fluency has issued a retraction notice advising that a previous news release from June 11, 2026, regarding CVS using Fluency to close enterprise AI deployment gaps should be disregarded by journalists and readers.

Thor Industries' Board of Directors approved a regular quarterly cash dividend of $0.52 per share, payable on July 15, 2026, to shareholders of record as of July 1, 2026. The company is the world's largest manufacturer of recreational vehicles.